Drug Discovery

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

How can we maximize the potential and production of potentially life-saving therapies?

Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.